Zobrazeno 1 - 10
of 62
pro vyhledávání: '"van Heeswijk RP"'
Autor:
R. M. W. Hoetelmans, van Heeswijk Rp, J. W. Mulder, Pieter L. Meenhorst, Lange Jm, Jos H. Beijnen, A.I. Veldkamp
Publikováno v:
Therapeutic drug monitoring, 23(3), 255-258. Lippincott Williams and Wilkins
The objective of this study was to evaluate the applicability of saliva as an alternative body fluid for therapeutic drug monitoring of nevirapine. The pharmacokinetics of nevirapine in plasma and saliva during a dosing interval was assessed in HIV-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c19557453f6aa6d3298f20030e0007
https://doi.org/10.1097/00007691-200106000-00012
https://doi.org/10.1097/00007691-200106000-00012
Autor:
J. W. Mulder, Jos H. Beijnen, Marthin O. Kwakkelstein, Lange Jm, F. W. Wit, Pieter L. Meenhorst, A.I. Veldkamp, Peter Reiss, van Heeswijk Rp, R. M. W. Hoetelmans
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes. :93-95
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9dbdaf9688c6c5747c1359048d8f430
https://doi.org/10.1097/00042560-200009010-00014
https://doi.org/10.1097/00042560-200009010-00014
Autor:
J. W. Mulder, R. M. W. Hoetelmans, J. H. Beijnen, Pieter L. Meenhorst, Lange Jm, A.I. Veldkamp, van Heeswijk Rp
Publikováno v:
Therapeutic drug monitoring, 23(6), 606-611. Lippincott Williams and Wilkins
The objective of this study was to develop and validate a limited sampling strategy (LSS) that allows accurate and precise estimation of the area under the plasma concentration versus time curve (AUC) of nevirapine, when used in the licensed dosage o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473b24bb1ed647e05db8fc46cd7c41c3
https://pure.amc.nl/en/publications/limited-sampling-strategies-for-the-estimation-of-the-systemic-exposure-to-the-hiv1-nonnucleoside-reverse-transcriptase-inhibitor-nevirapine(270fd036-c58a-4ce7-a6ae-8a95c0746055).html
https://pure.amc.nl/en/publications/limited-sampling-strategies-for-the-estimation-of-the-systemic-exposure-to-the-hiv1-nonnucleoside-reverse-transcriptase-inhibitor-nevirapine(270fd036-c58a-4ce7-a6ae-8a95c0746055).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Clinical Pharmacology; Jul2006, Vol. 46 Issue 7, p758-767, 10p
Autor:
Sandra De Meyer, Zobair M. Younossi, Gaston Picchio, R. Focaccia, Stuart K. Roberts, Don Luo, Andrzej Horban, Paul J. Pockros, Martyn Botfield, Maria Beumont, Eric Lawitz, Stefan Zeuzem, Pietro Andreone, Stanislas Pol, Jeroen Aerssens, Rolf van Heeswijk, Graham R. Foster
Publikováno v:
Journal of Hepatology. 58:883-889
Background & Aims Nucleotide polymorphisms upstream of the interleukin 28B ( IL28B ) gene are strongly associated with hepatitis C virus (HCV) clearance in treatment-naive patients treated with peginterferon/ribavirin (PegIFN/RBV). This subanalysis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc35585954b2af5702dc93d33bb3201
https://doi.org/10.1016/j.jhep.2012.12.023
https://doi.org/10.1016/j.jhep.2012.12.023
Autor:
Pym AS; Medical Research Council and Kwazulu Research Institute for TB and HIV (K-RITH), Durban, South Africa Alex.Pym@k-rith.org., Diacon AH; Division of Medical Physiology and Dept of Science and Technology/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research and Medical Research Council Centre for Tuberculosis Research, Faculty of Medicine and Health Sciences, University of Stellenbosch, Cape Town, South Africa., Tang SJ; Tuberculosis Dept, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumour Research Institute, Beijing, China., Conradie F; Clinical HIV Research Unit, Dept of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Danilovits M; Tartu University Lung Hospital, Tartu, Estonia., Chuchottaworn C; Chest Disease Institute, Ministry of Public Health, Nonthaburi, Thailand., Vasilyeva I; Central Tuberculosis Research Institute, Russian Academy of Medical Sciences, Moscow, Russia., Andries K; Janssen Infectious Diseases BVBA, Beerse, Belgium., Bakare N; Janssen Research & Development LLC, Titusville, NJ, USA., De Marez T; Janssen Research & Development LLC, Titusville, NJ, USA., Haxaire-Theeuwes M; Janssen Infectious Diseases BVBA, Beerse, Belgium., Lounis N; Janssen Infectious Diseases BVBA, Beerse, Belgium., Meyvisch P; Janssen Infectious Diseases BVBA, Beerse, Belgium., Van Baelen B; Janssen Infectious Diseases BVBA, Beerse, Belgium., van Heeswijk RP; Janssen Infectious Diseases BVBA, Beerse, Belgium., Dannemann B; Janssen Research & Development LLC, Titusville, NJ, USA.
Publikováno v:
The European respiratory journal [Eur Respir J] 2016 Feb; Vol. 47 (2), pp. 564-74. Date of Electronic Publication: 2015 Dec 02.
Autor:
McLeay SC; Model Answers Pty Ltd., Brisbane, Queensland, Australia sarah.mcleay@gmail.com., Vis P; Janssen Infectious Diseases BVBA, Beerse, Belgium., van Heeswijk RP; Janssen Infectious Diseases BVBA, Beerse, Belgium., Green B; Model Answers Pty Ltd., Brisbane, Queensland, Australia.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2014 Sep; Vol. 58 (9), pp. 5315-24. Date of Electronic Publication: 2014 Jun 23.
Autor:
van Heeswijk RP; Janssen Infectious Diseases BVBA, Beerse, Belgium rvheesw1@its.jnj.com., Dannemann B; Janssen Research & Development, LLC, Titusville, NJ, USA., Hoetelmans RM; Janssen Infectious Diseases BVBA, Beerse, Belgium.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2014 Sep; Vol. 69 (9), pp. 2310-8. Date of Electronic Publication: 2014 May 23.